Neuroendocrine Tumor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AQST | C | Aquestive Therapeutics, Inc. | 0.63 | |
CRNX | C | Crinetics Pharmaceuticals, Inc. | 4.04 | |
ABUS | D | Arbutus Biopharma Corporation | 1.83 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | C | ALPS Medical Breakthroughs ETF | 2.72 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.89 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 1.64 | |
MMSC | B | First Trust Multi-Manager Small | 1.24 | |
FTHI | B | First Trust High Income ETF | 0.89 |
Compare ETFs
Related Industries:
Biotechnology
- Neuroendocrine Tumor
A neuroendocrine tumor (NET) is a type of cancer that develops from cells of the neuroendocrine system. This system is made up of cells that release hormones in response to signals from the nervous system. Neuroendocrine tumors can occur anywhere in the body and can be benign (non-cancerous) or malignant (cancerous). Symptoms of NETs vary depending on the location and type of tumor, but may include abdominal pain, diarrhea, weight loss, and fatigue. Treatment options may include surgery, chemotherapy, radiation, and targeted therapy.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles